Clinical Significance of Decreased TIPE2 Expression in Peripheral Blood Mononuclear Cells of Patients with Psoriasis Vulgaris
Table 2
Basic demographic and clinical profile of the study groups.
Project/variable
Psoriasis (n = 33)
Controls (n = 31)
value
Sex (n (%))
0.599
Male
17 (51.52%)
18 (58.06%)
Female
16 (48.48%)
13 (41.94%)
Age, years mean ± SD
38 ± 18.04
42.87 ± 14.18
0.236
Family history (n (%))
Yes
13 (39.39%)
No
20 (60.61%)
Allergy history (n (%))
Yes
4 (12.12%)
No
29 (87.88%)
Infection history (n (%))
Yes
6 (18.18%)
No
27 (81.82%)
BMI (mean + SD)
24.19 ± 4.17
25.16 ± 3.35
0.308
<18.5
3 (9.09%)
0 (0%)
18.5–24.9
18 (54.55%)
17 (54.84%)
≥25.0
12 (36.36%)
14 (45.16%)
PASI score (n (%))
Mild (0–3)
1 (3.03%)
Moderate (3–10)
23 (69.7%)
Severe (≥10)
9 (27.27%)
Stages (n (%))
Active
25 (75.76%)
Stationary
8 (24.24%)
Quantitative variables are expressed as mean ± SD; categorical variables are expressed as n (%). An independent samples T-test was used to compare the mean values. Qualitative data were analyzed using the chi-squared test.
